rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Robert J. Deluccia

Director

Company insider

Files Form 4 as: Director and 10% owner, Acurx Pharmaceuticals; Executive Chairman, Dipexium Pharmaceuticals; President and CEO, Macrochem.

Every Form 4 they filed

In numbers

Trades disclosed
37
Buys
12
Sells
0
Bought
$210K
Sold
$0
Companies
3
Companies where not an officer
1
First trade
10 Feb 2006
Last trade
20 Apr 2026
Last filed
22 Apr 2026

Companies traded

Where they are an officer
Dipexium PharmaceuticalsDirector, Officer, 10% owner · last 17 Jan 20171 buy · 0 sells
MacrochemDirector, Officer · last 31 Dec 20078 buys · 0 sells
Everywhere else they filed: board seats, 10% stakes, other companies
ACXP Acurx PharmaceuticalsDirector, 10% owner · Biotechnology · last 20 Apr 20263 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
01Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
20 Apr 2026filed 22 Apr 2026ACXP Acurx Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code A—37,100 at $0.00filing
20 Apr 2026filed 22 Apr 2026ACXP Acurx Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code A—37,100 at $0.00filing
5 Feb 2025filed 6 Feb 2025ACXP Acurx Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code A—250,000 at $0.00filing
6 Jan 2025filed 8 Jan 2025ACXP Acurx Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code P—49,261 at $0.00filing
6 Jan 2025filed 8 Jan 2025ACXP Acurx PharmaceuticalsBiotechnologySEC FORM 4 Bought$50K49,261 at $1.02filing
23 Feb 2024filed 3 Apr 2024ACXP Acurx Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code A—250,000 at $0.00filing
3 Jan 2024filed 4 Jan 2024ACXP Acurx Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code M—19,737 at $0.00filing
3 Jan 2024filed 4 Jan 2024ACXP Acurx PharmaceuticalsBiotechnologySEC FORM 4 Code M$70K19,737 at $3.55filing
22 Dec 2023filed 4 Jan 2024ACXP Acurx PharmaceuticalsBiotechnologySEC FORM 4 Code G—30,000 at $0.00filing
12 Dec 2023filed 4 Jan 2024ACXP Acurx PharmaceuticalsBiotechnologySEC FORM 4 Code G—40,000 at $0.00filing
13 Feb 2023filed 24 Feb 2023ACXP Acurx Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code A—130,000 at $0.00filing
27 Jul 2022filed 29 Jul 2022ACXP Acurx Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code P—19,737 at $0.00filing
27 Jul 2022filed 29 Jul 2022ACXP Acurx Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code P—19,737 at $0.00filing
27 Jul 2022filed 29 Jul 2022ACXP Acurx PharmaceuticalsBiotechnologySEC FORM 4 Bought$75K19,737 at $3.80filing
2 Dec 2021filed 4 Jan 2024ACXP Acurx PharmaceuticalsBiotechnologySEC FORM 4 Code G—40,000 at $0.00filing
19 Nov 2021filed 22 Nov 2021ACXP Acurx PharmaceuticalsBiotechnologySEC FORM 4 Bought$25K5,034 at $4.90filing
1 Jul 2021filed 6 Jul 2021ACXP Acurx Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code A—500,000 at $0.00filing
29 Jun 2021filed 6 Jul 2021ACXP Acurx Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code A—350,000 at $0.00filing
17 Jan 2017filed 20 Apr 2017Dipexium Pharmaceuticalsoption or derivativeSEC FORM 4 Code A—183,332 at $0.00filing
19 Jan 2016filed 21 Jan 2016Dipexium Pharmaceuticalsoption or derivativeSEC FORM 4 Code A$356K35,000 at $10.16filing

News

Acurx Pharmaceuticals (NASDAQ:ACXP) Shares Climb 0.9% – Should You Buy?ACXP · dailypolitical.com · 22 Oct 2026

0 headlines in the last 90 days name Robert J. Deluccia; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.

Sectors

Health Care3
Not placed9

Buys in green, sells in red, by the company’s sector.

Related people

Nobody else traded the same names lately.